Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Overexpression of β1 integrin contributes to polarity reversal and a poor prognosis of breast invasive micropapillary carcinoma.

Liu B, Zheng X, Meng F, Han Y, Song Y, Liu F, Li S, Zhang L, Gu F, Zhang X, Fu L.

Oncotarget. 2017 Nov 30;9(4):4338-4353. doi: 10.18632/oncotarget.22774. eCollection 2018 Jan 12.

2.

Not like breast cancer, but like breast cancer: micrometastasis and micropapillary structure in lung cancer.

Masago K, Fujita S, Yatabe Y.

J Thorac Dis. 2017 Nov;9(11):4171-4173. doi: 10.21037/jtd.2017.09.105. No abstract available.

3.

Phosphorylated mTOR Expression Profiles in Human Normal and Carcinoma Tissues.

Lee H.

Dis Markers. 2017;2017:1397063. doi: 10.1155/2017/1397063. Epub 2017 Jul 31.

4.

High-Grade Urothelial Carcinoma of Bladder Transforming to Micropapillary Variant on Follow-Up.

Kumari N, Jha A, Vasudeva P, Agrawal U.

Iran J Med Sci. 2017 May;42(3):318-321.

5.

Micropapillary Bladder Cancer: Insights from the National Cancer Database.

Sui W, Matulay JT, James MB, Onyeji IC, Theofanides MC, RoyChoudhury A, DeCastro GJ, Wenske S.

Bladder Cancer. 2016 Oct 27;2(4):415-423. doi: 10.3233/BLC-160066.

6.

High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.

Nguyen D, Taheri D, Springer S, Cowan M, Guner G, Mendoza Rodriguez MA, Wang Y, Kinde I, VandenBussche CJ, Olson MT, Ricardo BF, Cunha I, Fujita K, Ertoy D, Kinzler KW, Bivalacqua TJ, Papadopoulos N, Vogelstein B, Netto GJ.

Virchows Arch. 2016 Oct;469(4):427-34. doi: 10.1007/s00428-016-2001-2. Epub 2016 Aug 12.

7.

Invasive micropapillary component and its clinico-histopathological significance in patients with colorectal cancer.

Jakubowska K, Guzińska-Ustymowicz K, Pryczynicz A.

Oncol Lett. 2016 Aug;12(2):1154-1158. Epub 2016 Jun 15.

8.

Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.

Guo CC, Dadhania V, Zhang L, Majewski T, Bondaruk J, Sykulski M, Wronowska W, Gambin A, Wang Y, Zhang S, Fuentes-Mattei E, Kamat AM, Dinney C, Siefker-Radtke A, Choi W, Baggerly KA, McConkey D, Weinstein JN, Czerniak B.

Eur Urol. 2016 Oct;70(4):611-620. doi: 10.1016/j.eururo.2016.02.056. Epub 2016 Mar 15.

10.

Phagocytosis (cannibalism) of apoptotic neutrophils by tumor cells in gastric micropapillary carcinomas.

Barresi V, Branca G, Ieni A, Rigoli L, Tuccari G, Caruso RA.

World J Gastroenterol. 2015 May 14;21(18):5548-54. doi: 10.3748/wjg.v21.i18.5548.

11.

Pulmonary metastasis in a patient with simultaneous bladder cancer and relapsing granulomatosis with polyangiitis.

Danckers M, Zhou F, Nimeh D, Belmont HM, Steiger DJ.

Am J Case Rep. 2015 May 14;16:287-91. doi: 10.12659/AJCR.893406.

12.

External beam radiotherapy for focal lymphoepithelioma-like carcinoma in the urinary bladder: a case report and literature review.

Kushida N, Kushakabe T, Kataoka M, Kumagai S, Aikawa K, Kojima Y.

Case Rep Oncol. 2015 Jan 14;8(1):15-20. doi: 10.1159/000371562. eCollection 2015 Jan-Apr.

13.

Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer.

Amin MB, Smith SC, Reuter VE, Epstein JI, Grignon DJ, Hansel DE, Lin O, McKenney JK, Montironi R, Paner GP, Al-Ahmadie HA, Algaba F, Ali S, Alvarado-Cabrero I, Bubendorf L, Cheng L, Cheville JC, Kristiansen G, Cote RJ, Delahunt B, Eble JN, Genega EM, Gulmann C, Hartmann A, Langner C, Lopez-Beltran A, Magi-Galluzzi C, Merce J, Netto GJ, Oliva E, Rao P, Ro JY, Srigley JR, Tickoo SK, Tsuzuki T, Umar SA, Van der Kwast T, Young RH, Soloway MS.

Mod Pathol. 2015 May;28(5):612-30. doi: 10.1038/modpathol.2014.158. Epub 2014 Nov 21. Review.

14.

Comparative study of conventional urothelial carcinoma, squamous differentiation carcinoma and pure squamous carcinoma in patients with invasive bladder tumors.

Gluck G, Hortopan M, Stănculeanu D, Chiriță M, Stoica R, Sinescu I.

J Med Life. 2014 Jun 15;7(2):211-4. Epub 2014 Jun 25.

15.

Clinical outcomes of cT1 micropapillary bladder cancer.

Willis DL, Fernandez MI, Dickstein RJ, Parikh S, Shah JB, Pisters LL, Guo CC, Henderson S, Czerniak BA, Grossman HB, Dinney CP, Kamat AM.

J Urol. 2015 Apr;193(4):1129-34. doi: 10.1016/j.juro.2014.09.092. Epub 2014 Sep 22.

16.

Cytological features of lung adenocarcinoma with micropapillary pattern in the pleural or pericardial effusion: analysis of 5 cases.

Ishida M, Kagotani A, Iwai M.

Int J Clin Exp Pathol. 2014 Jul 15;7(8):5111-6. eCollection 2014.

17.

Cytological features of pure micropapillary carcinoma of various organs: A report of eight cases.

Huq GE, Canberk S, Oznur M, Yildiz P, Bahadir B, Behzatoğlu K.

Oncol Lett. 2014 Aug;8(2):705-710. Epub 2014 May 29.

18.

Micropapillary bladder cancer: current treatment patterns and review of the literature.

Willis DL, Flaig TW, Hansel DE, Milowsky MI, Grubb RL, Al-Ahmadie HA, Plimack ER, Koppie TM, McConkey DJ, Dinney CP, Hoffman VA, Droller MJ, Messing E, Kamat AM.

Urol Oncol. 2014 Aug;32(6):826-32. doi: 10.1016/j.urolonc.2014.01.020. Epub 2014 Jun 13. Review.

19.

Invasive micropapillary carcinoma: a distinct type of adenocarcinomas in the gastrointestinal tract.

Guzińska-Ustymowicz K, Niewiarowska K, Pryczynicz A.

World J Gastroenterol. 2014 Apr 28;20(16):4597-606. doi: 10.3748/wjg.v20.i16.4597. Review.

20.

Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicine.

Wright GM, Do H, Weiss J, Alam NZ, Rathi V, Walkiewicz M, John T, Russell PA, Dobrovic A.

Oncotarget. 2014 Apr 30;5(8):2107-15.

Supplemental Content

Support Center